In our opinion, EVTSA to the mitral valve is safe and reproducible. It gives excellent exposure of the mitral valve under all circumstances without any significant increase in cross-clamp or bypass time, postoperative arrhythmia, heart block/pacemaker rate or bleeding.
Keyphrases
- mitral valve
- left atrial
- left ventricular
- end stage renal disease
- atrial fibrillation
- ejection fraction
- newly diagnosed
- chronic kidney disease
- minimally invasive
- patients undergoing
- heart failure
- peritoneal dialysis
- prognostic factors
- hypertrophic cardiomyopathy
- coronary artery bypass
- patient reported outcomes
- percutaneous coronary intervention